Cases of monkeypox has been reported in several countries recently. These include at least USA, UK, Portugal, Spain, and Sweden. It seems as if something is happening again. The mainstream media have launched a full-scale fear-mongering media artillery preparation, the like of which we hve never witnessed before. There are some similarities of introducing the COVID-19 epidemic. Operation Mockingbird? Streamlined mainstream parroting. That’s what the mainstream media does. But monkeypox, what is it? Is it serious? Is there a cure? No? How about a vaccine to prevent it? (Spoiler alert – yes!). What about monkey business? Any signs of it? Let’s have a look, shall we?
Monkeypox is a smallpox-like disease caused by a monkeypox virus, one of the human orthopoxviruses. It is not a variola virus which causes smallpox. As suggested by the name, the disease is found in monkeys but occasionally it can infect humans. With smallpox having been eradicated, monkeypox is now considered, by some, to be among the most dangerous viruses to humans.
Symptoms of the monkeypox begin with the usual symtoms of an infection, such as fever, headache, muscle aches, swollen lymph nodes, and fatigue. In the next phase, there appears a rash that forms blisters. The time from exposure to onset of symptoms is about ten days. Compared to smallpox, monkeypox typically presents with a milder rash and lower death rate. Typically, the duration of symptoms ranges from two to four weeks. Diagnosis can be established by PCR tests from samples of skin lesions but not from blood samples.
There is no specific treatment for monkeypox. Antivirals, such as cidofovir or brincidofovir may be of some use. Cidofovir is an injectable antiviral drug, used to treat retinitis caused by cytomegalovirus in individuals with AIDS, and which has some efficacy against smallpox. Brincidofor has been developed from cidofovir, and it is more effective against smallpox, and can be taken orally. Other treatment focuses on the symptoms.
As you might expect, there is a vaccine against such a rare disease which, alledgedly, can prevent infection with 85% effectiveness. Might this number reflect the relative risk reduction? Be that as it may, in 2019,a vaccine for monkeypox was approved by the US Food and Drug Administration (FDA).
History of Monkeypox
Monkeypox virus was first discovered in 1958, in monkeys, hence the name. To be more specific, it was discovered by a great Dane, Preben von Magnus, in macaques, a monkey species commonly used in research laboratiorios, like his own. Based on his research, he became a Knight of the Order of the Dannebrog in 1965, having come to the conclusion that respiratory viruses such as influenza and the common cold were unsuitable as biological weapons. His stance on the suitability of monkeypox as a bioweapon is not known. He did, however, note that the virus bears some similarities with smallpox.
In 1968, the WHO reported that suspected outbreaks of monkeypox in institutes around the globe might not be rare. In 1970 the virus was identified in humans. Between 1970 and 1979 some 50 cases of monkeypox in humans were reported, with more than two thirds of these being from the Democratic Republic of Congo, formerly Zaire.
By 1986, in excesss of 400 cases in humans had been reported. Small viral outbreaks with a death rate in the range of about 10% and a secondary human-to-human infection rate of about the same magnitude occurred in the region.
Between February and August of 1996, 71 cases of monkeypox were found in Zaire, spread in 13 villages. This gained attention because it was dicovered that most, if not all, cases were suspected to having been transmitted from humans to humans.
The first reported monkeypox outbreak outside the African continent occurred in the Midwestern United States in 2003. The outbreak was traced back to a prairie dogs, which had the infected by Gambian pouched rats, which had been imported to the USA.
The outbreak resulted in 71 individuals in six states getting infected with monkeypox, and no deaths were detected.
(When entering the USA, what is the first question you are asked, if you arrive via customs, and not across the Rio Grande mud?)
The first case of monkeypox in humans in the UK was discovered in September 2018 in a Nigerian citizen, who was believed to have contracted monkeypox in Nigeria before traveling to the UK.
Arguably, the disease in humans has so far been relatively, if not, extremely rare. A quriosity even. To argue that the virus is particularly harmful to humans would be an overstatement.
So far data show that an outbreak seems to have infected exactly 71 individuals, and had not resulted any deaths, at least not outside of Africa.
It is also worth noting that Gambian pouched rats are absent from most Zaire, where Emin’s pouched rat is the dominate species, having beaten Gambian pouched rats in the Darwinian natural selection championships.
Duodecim on Monkeybox in 1999
”Compared to smallpox, monkeypox appears to be much milder, at least for now, but the cessation of smallpox vaccination has created a new, more serious threat: the potential use of the smallpox virus as a bioweapon.”
In addition to the smallpox, an editorial in the Finnish Medical Journal Duodecim in 1999 discussed the dangers of monkeypox from the perspective of its possible use as a bioweapon. Given that the Smallpox was officially declared eradicated in 1980. Until then, everyone was vaccinated against smallpox – which also protected against monkeypox. This opened monkeypox a door to be used as a bioweapon.
Because of the limited number of individuals infected with monkeypox in certain designated areas, there really is no natural immunity against monkeypox in larger populations. There really was no herd immunity against smallpox, save for milkmaids infected with cowpox. Moreover, there is no specific treatment for neither disease. As a result, monkeypox would be a very good biological weapon. It may also spread easier than thought. A study from Zaire proposed that one infected individual would, in turn, infect eight other.
For some reason, recent articles in the mainstream media propose that monkeypox is only transmitted in gay relationships between males, despite everything that is already known by now. While this argument in reality is not true, one should bear in mind that AIDS was introduced to the world by the media as ”gay plague”.
Sequels are boring, the level of mainstream journalism has hit the rock bottom, and the content they are trusted to parrot, is mainly believed those who do not know how to use other sources of media, or have been brainwashed not to believe it. ”Russian disinformation!”
The discovery of monkeypox virus is linked to development of polio vaccinations by von Magnus. They were made using monkey kidney cells, and the safety of the vaccine batches was tested on monkeys imported mainly from Asia and West Africa. Not much attention was paid to the monkeypox virus at the time, given that it was mild in comparison to the smallpox virus, and because the smallpox vaccine was effective against it.
Monkeypox Outbreaks in 2022
In the very recent days, the mainstream media has been abuzz with news of monkeypox outbreaks around the world. Most recently in Sweden. Monkeypox has also been found in the USA, Canada, the UK, Australia, Portugal, and Spain in the last few days. There is a flavor of a coordinated media coverage to it.
This outbreak is strange, given that, as long as the smallpox virus has been known to exist, the disease has been extremely rare, not just throughout the world, but even within the endemic region in Africa.
Obviously something is happening, with the cases now suddenly being reported around the globe. Only we don’t know what. Have we larned anything from the Covid-19 epidemy, or will we, or our leaders, repeat all the mistakes they did regarding that nothingburger.
The media coverage, while loud, strikes to an educated reader as lazy, and unoriginal. Worse yet, the quality of the news coverage is such that it can be debugged in minutes. It should also be noted that the usual pests – fact-checkers – seem all to have a day, or a week, off.
JYNNEOS – The Monkeypox Vaccine!
The US Centers for Disease Control and Prevention (CDC) reports that the smallpox vaccine, cidofovir, ST-246, and vaccine immunoglobulin (VIG) can be used to control the monkeypox outbreak.
One vaccine, JYNNEOS, has been approved in the United States for the prevention of monkeypox and smallpox. As stated above, the FDA has approved the JYNNEOSTM vaccine, marketed by Bavarian Nordic A/S already in 2019.
The JYNNEOS vaccine is not currently available to the general public.
So – there is a vaccine for monkeypox – but it is not widely available, and not available at all for the great public.
It’s great that there is a vaccine to a virtually non-existent disease, which has recently been approved by the FDA, but which is not available for public. Not quite yet… The people have not yet been saturated with horror stories and fear-mongering regarding monkeypox.
Does the media keep people under suspicion at this point? Make them more susceptible for the coverage to come? Submissive to future lockdowns, mask mandates, and all the measures that never were of any help, not that there was any particular need for help to begin with. The goverments have consulted behavioral analysts before, why not now?
Who Supported the Development of the Monkeypox Vaccine?
Oh well, it was, at least, The National Institutes of Health (NIH), which handed $100 million to the Bavarian Nordic A/S and Acambis for vaccine development, already in 2006.
The NIH officials provided not just money but, in addition to that, the NIH provided Acambis with samples of the modified smallpox virus used by Bavarian Nordic A/S, prompting Bavarian Nordic A/S to file a civil lawsuit against Acambis. Acambis seems to be a subsidiary of the Sanofi pharmaceutical company.
The Wuhan SARS-CoV Case
On 8 Sep 2021 the following was reported: Wuhan lab researched and modified bat coronaviruses – with US funding”.  The article writes about research conducted on the Wuhan Virology Research Institute in China, with a mission to identify and modify coronaviruses that could infect humans. The article also reported that the Institute received funding from the US government. The studies conducted in Wuhan turned out to be gain-of-function studies, in which the SARS-CoV virus was engineered to make it more infectious to humans by adding a bat spike protein in it to ”spike it up”. The virus is now known as the SARS-CoV-2.
Bavarian Nordic A/S
Bavarian Nordic A/S is a Danish company. The CEO of the company is Paul Chaplin.
In addition to monkeypox vaccine, Bavarian Nordic A/S has received marketing authorization for Ebola and Marburg virus vaccines from the FDA in July 2020. Ebola and Marburg are both extremely serious hemorrhagic virus infections. Marburg virus has been classified to belong to a risk group 4 bioterrorism. Monkeypox has been classified to belong to biohazard class 3.
The future of Bavarian Nordic A/S economy looks bright. In 2021, it made a profit of $190 million. Bavarian Nordic A/S foresaw Bavarian Nordic A/S as so good a company, it decided to buy back its own stock. On May 18, 2022, the company announced the end of its share buyback program. The company bought back 71,562 Bavarian Nordic A/S shares between 9 and 18 May 2022. It’s almost as if the saw to the future. It’s almost as if they saw… A monkeypox outbreak.
Biomedical Advanced Research and Development Authority (BARDA)
The Biomedical Advanced Research and Development Authority (BARDA) purchased $119 million worth of JYNNEOS® vaccines for 2023-2024, or 13 million doses. The purchase was announced on May 18, 2022.
Prior to that, almost exactly one year ago, on May 7, 2021, Bavarian Nordic’s press release mentioned that BARDA had exercised a $12 million option for a total $202 million order booked for 2020-2022.
According to these figures, BARDA has ordered $321 million worth of monkeypox vaccines over two years!
The World’s Biological Weapons Laboratories – Are There Any?
Below, journalist Dilyana Gaytandzhieva asks Robert Kadlec, the Assistant Secretary of Health and Human Services (Preparedness and Response) at the 2018 European Parliament about US biological weapons laboratories and programs in Ukraine and Georgia.
See the full documentary – Pentagon Biolaboratories – Investigative Documentary
Bavarian Nordic A/S share value
I have written before about the common stock market fluctuations of pandemic drugs before the onset of a pandemic.
Monkeypox Has Been Rare So Far
I couldn’t find any reference to JYNNEOSTM vaccine campaigns anywhere in the world. The number of clinical trials is also quite scarce. I did, however, find one clinical trial. Only that trial is about a smallpox vaccine (IMVAMUNE). Vaccines by Bavarian Nordic A/S, Imvamune and Imvanex, are different vaccines from JYNNEOStm.Their timeline of research and development to licensing didn’t match that of JYNNEOSTM.
According to the FDA, the immune response of the JYNNEOSTM vaccine has been measured in 400 individuals. Obviously, true efficacy cannot be measured from such a sample given that the virus is so rare. In safety trials, 7,800 individual have received the vaccine.
In addition to monkeypox everywhere, in the developed countries mumps has been rare for quite some time. Despite that, in the last year alone, tens of millions of doses of vaccine have been reserved for it.
Is Pandemic, Version 2.0, Happening Now?
This case follows the same pattern as the SARS-CoV-2 epidemy. The NIH has been funding pharmaceutical companies under the guise of fighting bioterrorism, and SARS-CoV-2 appears to be a designer virus. Are we about to go through the same farce again?
The world is now keenly aware of the incipient ”pandemic” and the shortage of vaccines. Bavarian Nordic’s share buyback program started at the same time as the first information about the outbreak became public. Share buyback programs are regulated by (EU) 2016/1052, which is how we know the timeline.
After the Bavarian Nordic A/S ended the buyback program on 18 May 2022, the news of BARDA’s $119 million JYNNEOS vaccine deal was announced, and the company stock skyrocketed.
The next day, on May 19, 2022, Bavarian Nordic A/S announced that it has closed a deal ”with an undisclosed European country” to supply it with JYNNEOS® vaccines.
Munich Security Conference Simulated Monkey Pox Pandemic
Prior to the COVID-19 pandemic, ”Event 201” was held in October 2019 to simulate a coronavirus outbreak. – It happened as planned!
The Nuclear Threat Initiative (NTI) held a similar exercise on monkey pox in November 2021. Representatives, or the usual suspects, all attended. According to the November 2021 simulation, the monkey pox will be released on 15 May 2022.
On June 5th, an international emergency will be declared.
And if we haven’t learned anything from the COVID farce, we are doomed to play along for, only God knows how long.
It was Shakespeare himself, who said ”There’s some monkey business in Denmark!”
He went on to say, more famously than the previous quote, ”To pandemy or not to pandemy, ay that’s the rub!”
And he never even answered the question.
The big question now is: Has the pandemic version 2.0 been released?
Is it as bad as Windows 11?
And, is the world’s biggest vaccine campaign just about to begin?
P.S. If you did get the impression that a modified virus, with the original virus found by a – Knight of The Order of the Dannebrog – is of no natural origin, it was deliberately released, and you don’t understand why anyone would do such a thing, you might find the Revealing Symbols series of articles interesting. Revealing Symbols will lead you through history from past to the present, and perhaps help you understand what is happening in the world right now. Bookmark ”The Jab”, and follow him on Twitter to stay tuned.
 Monkeypox https://en.wikipedia.org/wiki/Monkeypox
 Poxviridae https://en.wikipedia.org/wiki/Poxviridae
 The smallpox is gone – will it be replaced by monkey pox? https://www.duodecimlehti.fi/duo90095
 A very rare monkey pox has landed in Sweden – the origin of the new sighting is unknown https://www.mtvuutiset.fi/artikkeli/erittain-harvinainen-apinarokko-rantautui-ruotsiin-uuden-havainnon-alkuperaa-ei-tiedeta/8430914#gs.0nfipv
 Smallpox and monkeypox treatment CDC https://www.cdc.gov/poxvirus/monkeypox/clinicians/treatment.html#anchor_1545414760080
 Smallpox and Monkeypox Vaccine, Live, Non-Replicating https://www.fda.gov/vaccines-blood-biologics/jynneos
 Bavarian Nordic https://en.wikipedia.org/wiki/Bavarian_Nordic
 Marburg virus https://en.wikipedia.org/wiki/Marburg_virus
 Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program https://www.globenewswire.com/news-release/2022/05/18/2446347/0/en/Bavarian-Nordic-Transactions-in-Connection-with-Share-Buy-Back-Program-and-Termination-of-Share-Buy-Back-Program.html
 Monkeypox case confirmed in England https://www.bbc.com/news/uk-61363896
 Buyback of Shares https://www.ouryclark.com/resource-library/quick-guides/corporate/buyback-of-shares.html
 Gain-of-Function Deliberative Process Written Public Comments https://osp.od.nih.gov/wp-content/uploads/2013/06/Gain_of_Function_Deliberative_Process_Written_Public_Comments.pdf
 U.S. GOVERNMENT EXERCISES OPTION FOR SUPPLY OF ADDITIONAL SMALLPOX VACCINES FROM BAVARIAN NORDIC https://www.bavarian-nordic.com/investor/news/news.aspx?news=6333
 Jynneos packing station https://www.fda.gov/media/131078/download
 WHO recommended a drug whose EFFECT IS IMPOSSIBLE – Now a new drug is recommended! https://injektiopiikki.com/2021/09/12/who-on-estanyt-covid-19-varhaisen-hoidon-suosittaa-laaketta-jonka-hinta-on-yli-2000e-potilas-ja-teho-pyorea-nolla/
 Lab Leaks Are a Small But Real Risk in Ukraine https://time.com/6162111/ukraine-lab-leaks-disinformation/
 JYNNEOS trials https://www.rxlist.com/jynneos-drug.htm#description
 Wall Street Journal Examines NIH Funding for Anti-Bioterrorism Medications, Vaccines https://khn.org/morning-breakout/dr00034151/
 Acambis https://ezlocal.com/ma/canton/pharmacy/09218752
 The Intercept: Wuhan lab studies and modifies bat coronaviruses – with US funding https://yle.fi/uutiset/3-12090742
 COMMISSION DELEGATED REGULATION (EU) 2016/ 1052 https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R1052&from=EN
 BAVARIAN NORDIC SECURES VACCINE ORDER FROM EUROPEAN COUNTRY AFTER CONFIRMED MONKEYPOX CASES https://www.bavarian-nordic.com/investor/news/news.aspx?news=6574
 Intellectual Property: Patent war over smallpox vaccine https://sciencebusiness.net/news/73868/Intellectual-Property%3A-Patent-war-over-smallpox-vaccine
 Recombinant Modified Vaccinia Virus Ankara (MVA) Filovirus Vaccine (Marburg virus) https://patents.google.com/patent/US20200268872A1/en?assignee=Bavarian+Nordic+A%2fS&oq=Bavarian+Nordic+A%2fS
 Pathogen Safety Data Sheets: Infectious Substances – Monkeypox virus https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/monkeypox-virus.html
 Pentagon Biolaboratories – Investigative Documentary https://www.youtube.com/watch?v=_8hQi2Zv1L0
 Robert Kadlec https://en.wikipedia.org/wiki/Robert_Kadlec
 Dilyana Gaytandzhieva https://www.linkedin.com/in/dilyana-gaytandzhieva-1740aa112/?originalSubdomain=uk – https://armswatch.com/
 Preben von Magnus https://en.wikipedia.org/wiki/Preben_von_Magnus
 FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox https://www.fda.gov/news-events/press-announcements/fda-approves-first-live-non-replicating-vaccine-prevent-smallpox-and-monkeypox